Protocol Ledger

NCT06520176 · Phase III · RECRUITING

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

Interventional Phase III clinical trial protocol NCT06520176 sponsored by The Affiliated People's Hospital of Ningbo University in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-08-01 Enrollment: 99 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06520176
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)99 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06520176
Protocol FieldVerified Registry Value
NCT IdentifierNCT06520176
Consolidated Lead SponsorThe Affiliated People's Hospital of Ningbo University
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment99 participants (ESTIMATED)
Registered Start Date2024-08-01
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI